Imunon CEO granted 1,491 IMNN shares as salary stock

Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Lindborg Stacy reported acquisition or exercise transactions in this Form 4 filing.

Imunon, Inc. President and CEO Stacy Lindborg reported a stock grant of 1,491 shares of Common Stock. The shares were granted at $2.20 per share as stock in lieu of a portion of base salary, making this a compensation-related award rather than an open-market purchase.

After the grant, Lindborg directly holds 3,642 shares of Imunon common stock and indirectly holds 778 shares through a 401(k) plan. The filing does not show any open-market buying or selling activity.

Insider Trade Summary

Grant/Award: 1,491 shares

Grant/Award 2 txns

Insider Lindborg Stacy

Role President and CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,491	$2.20	$3K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 3,642 shares (Direct); Common Stock — 778 shares (Indirect, By 401(k) Plan)

Footnotes (1)

1. F1. Stock granted in lieu of cash for portion of base salary

Key Figures

Stock grant size: 1,491 shares Grant valuation price: $2.20 per share Direct holdings after grant: 3,642 shares +2 more

5 metrics

Stock grant size 1,491 shares Common Stock granted as compensation on 2026-05-22

Grant valuation price $2.20 per share Recorded price for the 1,491-share grant

Direct holdings after grant 3,642 shares Imunon Common Stock directly owned after transaction

Indirect 401(k) holdings 778 shares Imunon Common Stock held indirectly via 401(k) Plan

Acquire-type transactions 1 transaction Grant/award acquisition reported in transaction summary

Key Terms

Common Stock, grant/award acquisition, 401(k) Plan, Form 4

4 terms

Common Stock financial

"Stacy Lindborg received a grant of 1,491 shares of Common Stock."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

grant/award acquisition financial

"The transaction is classified as a grant/award acquisition with code A."

401(k) Plan financial

"Lindborg also indirectly holds 778 shares by 401(k) Plan."

A 401(k) plan is a workplace retirement account that lets employees set aside part of their pay into a tax-advantaged savings pot, often with employers adding matching contributions — like a workplace piggy bank for future income. It matters to investors because the amount people save and how employers fund these plans influence consumer spending, corporate payroll costs and the flow of money into financial markets, which can affect stock prices and company valuations.

Form 4 regulatory

"The Form 4 shows a grant of 1,491 shares coded as an acquisition."

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Imunon (IMNN) report for Stacy Lindborg?

Imunon (IMNN) reported that President and CEO Stacy Lindborg received a grant of 1,491 shares of Common Stock. The award was issued as stock in lieu of part of her base salary, making it a compensation grant rather than an open-market trade.

At what price was Stacy Lindborg’s Imunon (IMNN) stock grant recorded?

The 1,491-share grant to Stacy Lindborg was recorded at $2.20 per share. This price is used to value the compensation award and does not represent an open-market purchase or sale on that date according to the Form 4 details.

How many Imunon (IMNN) shares does Stacy Lindborg hold after this Form 4 filing?

Following the reported transactions, Stacy Lindborg directly holds 3,642 shares of Imunon Common Stock. She also has indirect ownership of 778 shares through a 401(k) plan, giving insight into her combined reported equity exposure in the company.

Was Stacy Lindborg’s Imunon (IMNN) Form 4 transaction a market buy or sell?

The Form 4 shows a grant of 1,491 shares coded as an acquisition, not an open-market buy or sell. A footnote clarifies the stock was granted in lieu of cash for a portion of her base salary, classifying it as compensation.

What does the 401(k) Plan entry mean in the Imunon (IMNN) Form 4?

The Form 4 reports 778 Imunon shares held indirectly by Stacy Lindborg through a 401(k) Plan. This entry reflects existing retirement-plan holdings as of the transaction date, categorized as indirect ownership, and does not represent a new open-market transaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/27/2026 - 04:11 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lindborg Stacy

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NEW JERSEY 08648

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/22/2026		A		1,491(1)	A	$2.2	3,642	D
Common Stock								778	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Stock granted in lieu of cash for portion of base salary

Remarks:

On August 21, 2025, the Issuer paid a 15% stock dividend, 0.15 shares of common stock per share of the Issuer's issued and outstanding shares of common stock, to stockholders of record as of August 7, 2025. As a result of the stock dividend, the shares of Issuer Common Stock have been adjusted accordingly versus any amounts previously reported by the Reporting Person.

	/s/ Susan Eylward, Attorney-in-Fact for Stacy Lindborg	05/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)